MDQK.HM (MediNavi AG) HAM up 200% 22 Jan 2026: check liquidity and targets
MDQK.HM stock jumped 200.00% to €7.50 in HAM market hours on 22 Jan 2026, driven by a sharp intraday gap and very low liquidity. The move widened the day range from €2.50 to €7.50 on volume of 35 shares versus an average volume of 41. This small-cap healthcare name, MediNavi AG, shows a 50-day average price of €2.50 and a 200-day average of €2.00, which signals a large intraday breakaway. Traders should treat intraday gains with caution given missing earnings data and limited free float.
MDQK.HM stock intraday snapshot
Intraday fact: MDQK.HM stock closed at €7.50, up €5.00 or 200.00% from the previous close of €2.50. Volume was 35, below the average of 41, pointing to low liquidity. The stock posted a day low of €2.50 and a day high of €7.50 on the HAM exchange in Germany. This pattern suggests a thinly traded security can swing widely on small orders or a single block trade.
Technical snapshot and short-term levels for MDQK.HM stock
Key technicals: the 50-day average is €2.50 and the 200-day average is €2.00, both much lower than the current price. ATR is 5.00, reflecting extreme intraday volatility. No reliable RSI or MACD signals exist due to sparse history. Immediate support sits near the open at €2.50, with intraday resistance at the high of €7.50. For active traders, a narrow stop below €2.50 is prudent given the gap.
MDQK.HM stock fundamentals and sector context
MediNavi AG operates a patient-doctor matching and second-opinion platform based in Munich, Germany. Public filings show no EPS or PE ratio available, and market capitalization is not reported. Key balance metrics include a current ratio of 41.50 and working capital of €269,922.60, reflecting a cash-rich but very small operating base. In the Healthcare sector, the average PE is 31.28, which is not comparable here because MDQK.HM lacks earnings data.
Meyka AI grade and forecast for MDQK.HM stock
Meyka AI rates MDQK.HM with a score of 58.52 out of 100 — Grade C+ | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector and industry performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a base-case price of €3.25 for MDQK.HM stock. Versus the current price of €7.50, that implies a downside of -56.67%. Forecasts are model-based projections and not guarantees.
Trading implications, price targets and risks for MDQK.HM stock
Given the jump and low volume, MDQK.HM stock is a high-risk trade in HAM market hours. Short-term price targets: conservative target €3.25 (base), bullish scenario €12.00 (upside). Support near €2.50, stop-loss recommended below that level. Main risks include missing public float data, no EPS or analyst coverage, and possible reversal to pre-spike averages. Use small position sizes and strict risk controls.
Catalysts and next steps for MDQK.HM stock
Watch for company announcements, partner deals, or regulatory news that could justify the jump. No earnings date is listed. Monitor order book depth on HAM and any filings on the company website. For primary sources see the MediNavi site and the public profile image below. Internal reference: check the Meyka stock page for live signals and alerts.
Final Thoughts
MDQK.HM stock posted a dramatic intraday move to €7.50 on 22 Jan 2026, but the advance came on very low volume of 35 shares and without earnings confirmation. Our technical read shows wide dispersion from the 50-day average of €2.50 and an ATR of 5.00, which increases the likelihood of quick mean reversion. Meyka AI’s forecast model projects a base-case of €3.25, implying -56.67% from the current price. The Meyka grade is 58.52 (C+, HOLD), reflecting weak fundamentals and sparse liquidity. Traders seeking exposure should size positions small, set strict stops under €2.50, and wait for verified corporate news or higher sustained volume before treating MDQK.HM as a tradable momentum name. Forecasts are model-based projections and not guarantees.
FAQs
What caused the MDQK.HM stock jump today?
The intraday jump to €7.50 was driven by a thin order book and low liquidity. Volume was 35 versus an average of 41. No public earnings or corporate announcement was posted at the time of the move.
What is Meyka AI’s forecast for MDQK.HM stock?
Meyka AI’s forecast model projects a base-case price of €3.25 for MDQK.HM stock. That implies a downside of -56.67% from the current €7.50. Forecasts are projections and not guarantees.
How risky is trading MDQK.HM stock on HAM?
Trading MDQK.HM stock is high risk due to low liquidity, missing EPS data, and no market cap disclosure. Use small position sizes, strict stops, and confirm any catalyst before increasing exposure.
Where can I find company information for MDQK.HM stock?
Primary company details are on the MediNavi AG website. For market profile and visuals, check the company profile image used by public data providers. Always cross-check filings before trading.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
